All 36 GLP-1 providers, side-by-side

Pros

• +Compounded semaglutide runs as low as $117 a month on the annual plan with the NYNY12 code printed on its pricing page, against $279 month to month
• +Includes 1-on-1 nutrition coaching and weekly check-ins, not just medication prescriptions
• +Sells brand-name Ozempic, Zepbound and Wegovy alongside compounded semaglutide and tirzepatide, with an insurance concierge that helps you pursue coverage for the brand-name option through your own plan

Cons

• −The lowest advertised compounded prices require an annual commitment and a promo code
• −Compounded medication and virtual visits are cash-pay. Fridays offers insurance and prior-authorization support for brand-name medication, but coverage and your out-of-pocket cost depend on your plan.

Pros

• +Clinician visits and shipping are included in the standard injection plans; consultations are usually available the same day, according to bmiMD
• +An established public Trustpilot profile: 4.4/5 from 871 reviews, checked September 12, 2026
• +No charge if the clinician finds you ineligible: bmiMD says it releases the card authorization hold

Cons

• −The $119/mo semaglutide headline is a 12-month plan billed $1,428 up front, and the refund policy says all sales are final with no refunds for partially used subscription periods. Paying one month at a time costs $159 for semaglutide and $249 for tirzepatide
• −Brand-name Zepbound, Ozempic and Mounjaro are sold but kept out of the site navigation, and their prices surface only inside the weight loss quiz at $233/mo, $249/mo and $249/mo. Ask for them by name if a brand-name drug is what you want
• −A $50 non-refundable cancellation fee applies once your intake form is sent, which is earlier than approval; decide before you order, and cancel at least 48 hours ahead of your monthly processing date

Pros

• +Success by Sesame is $59/mo on the 12-month commitment and includes provider visits, unlimited messaging and provider choice; lab work is covered only at Quest Diagnostics and not in AZ, HI, ND, NJ, NY, OK, RI, SD or WY, where lab fees are extra; medication is separate
• +Brand-name cash pricing is competitive, Wegovy pen $199 intro / $349 ongoing, Zepbound vial $299, Wegovy pill $149
• +Foundayo (Lilly's FDA-approved oral GLP-1) available as of April 2026 at $149/mo

Cons

• −Sesame runs three separate routes under one brand: the Success by Sesame weight loss subscription, EverydayRx for diabetes, and one-off visits from $34. Check which one you are signing up for before you pay.
• −The $59/mo Success by Sesame rate applies only on a 12-month commitment. The 3-month plan works out near $79/mo and the 6-month near $69/mo from the savings the FAQ publishes, and the no-commitment plan is $99 billed every 28 days, which is 13 charges a year.
• −There is no compounded option. Sesame states that compounded semaglutide is not currently available through it, so every route here is brand-name and the medication is billed on top of the program fee.

Pros

• +The published $297/mo compounded semaglutide injection tier includes medication, consultations, shipping, and pharmacy fees
• +Format-specific prices are published on the site, which makes the advertised medication and service bundle easier to compare
• +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval

Cons

• −Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
• −Injectable compounded semaglutide is $297 a month and the sublingual drops are $249 a month on the product page, so the cheaper in-house format saves $48, and both sit above the lowest cash-pay entry prices in this comparison
• −BBB shows 248 complaints and roughly 1.1/5 customer-review stars, with recurring reports of unauthorized charges, cancellation difficulty, billing confusion, and unfulfilled or delayed orders

Pros

• +Same price at every dose, so titrating up does not raise the monthly bill. GLP-1 Core is $212/mo on the 12-month plan and $249/mo month to month (verified 2026-09-03)
• +The monthly price covers lab work, the video visit with a provider, medication from a partner pharmacy and 2-day shipping, with no separate consultation fee
• +Support is staffed seven days a week, Monday to Friday 8:00 AM to 8:00 PM EDT and Saturday to Sunday 9:00 AM to 5:00 PM EDT, by phone and email

Cons

• −The $212/mo headline is the 12-month plan, billed every 48 weeks. Paying month to month costs $249/mo on the GLP-1 Core pricing page (verified 2026-09-03)
• −Compounded only. Every GLP-1 product page states the formulation is not FDA-approved and is compounded under federal Section 503A guidelines, and no brand-name product is sold
• −Not nationwide. The FAQ lists 40 states plus DC and leaves out Alabama, Arkansas, Georgia, Hawaii, Louisiana, Mississippi, Missouri, North Dakota, South Carolina and Tennessee

Pros

• +Clinical-service-only path to brand Wegovy and Zepbound at $99/mo, prescription goes to patient's pharmacy (you fill separately using insurance or cash)
• +Steep multi-month commitment discounts on compounded sema, $158/mo on 12-month plan ($1,900 upfront) vs $249/mo month-to-month
• +Same price at all dose levels for compounded, no cost escalation as you titrate up

Cons

• −The $99/mo Wegovy or Zepbound tier buys the prescription and provider oversight only. TMates says it does not dispense or ship the drug, and no price for the medication itself appears on its product or category pages, so your own pharmacy bills you separately (checked 2026-09-03).
• −The best compounded rates require prepayment: $1,050 upfront for 6 months, $1,900 for 12. Start at $249 month-to-month if you want to test fit first.
• −The intake is a 90-second quiz. Fast, but lighter screening than competitors with full medical intakes. Better suited to patients who already know GLP-1 basics.

Pros

• +Prices are public before you fill in anything: the shop page and every checkout listing show the monthly rate and the total billed, with free consultation, free shipping and no membership fee
• +Fast dispatch: the site says medication typically ships within 48 hours of approval, with delivery quoted at 2 to 5 business days in its own FAQ
• +No doctor visit required in most states, maximally convenient for patients who don't want appointments

Cons

• −The treatment consent you sign commits you to the first three months of medication fees even if you stop, and those fees are non-refundable once paid. Budget for the full commitment, not a single month.
• −No video or phone consultation in most states; providers review your intake asynchronously. Maximum convenience, but pick a platform with regular check-ins if you want closer clinical oversight.
• −The company names itself DudeMeds LLC, incorporated in Delaware on its terms of sale page and in Florida on its terms and conditions page, both dated January 1, 2024, and its only published address is a mail suite. Pharmacies are described as third-party 503A or 503B partners but never named, so ask which one fills your prescription before ordering.

Pros

• +One flat price at any dose, Shed's pricing page states the monthly price never rises as the dose escalates
• +$199/mo is competitively priced for an all-inclusive compounded program with good support
• +Onboarding is fully online and asynchronous in many states, with same day approval advertised, though Shed says some states require a video visit before treatment

Cons

• −Brand name Wegovy, Zepbound and Foundayo sit behind a separate Shed membership, quoted at $125 a month on all three product pages, with the medication billed on top by the dispensing pharmacy. The small print on the Wegovy and Zepbound pages still says $99, so Shed's own pages disagree on the figure.
• −Short track record and thin published outcome data. A founding date is not shown on the site's about, contact, terms or FAQ pages (rendered check 2026-09-03), and the best evidence available is a 4.7 Trustpilot score across 1,129 reviews on a profile claimed in April 2025
• −Shed does not bill insurance, so the compounded program is cash pay, though it accepts HSA and FSA cards, posts downloadable receipts for reimbursement, and includes prior authorization and appeals support on the brand name route

Pros

• +Includes monthly provider check-ins and dose adjustments at no extra cost
• +Compounded daily dissolving tablets for semaglutide and tirzepatide, offering a needle-free format to discuss with the prescriber
• +$299/mo covers compounded semaglutide at the starting doses, injectable or tablet, with monthly provider support and no separate consultation fee

Cons

• −Compounded-only, no brand-name Wegovy or Zepbound through the platform
• −Both headline prices are floors. Tirzepatide starts at $399/mo against $299 for semaglutide, and on the help center pricing article maintenance tirzepatide injections run $499/mo from 8.5 mg, $524/mo at 13.5 mg and $549/mo at 17 mg (checked 2026-09-03)
• −Cash-pay only. Willow does not bill insurance. You pay with an HSA or FSA card at checkout, or pay out of pocket and submit receipts to your insurer yourself, with reimbursement depending on your plan and deductible (checked 2026-09-03)

Pros

• +Oral dissolving tablets exclusively, zero injections for any GLP-1 option
• +Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
• +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment

Cons

• −Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
• −Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
• −Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Pros

• +A $167/mo starting price on its compounded semaglutide page, with no membership fee, free shipping and free health coaching included
• +Every dose costs the same, so moving to a higher dose during titration does not raise the monthly bill, stated on the product page and in the blog
• +Three compounded routes including a non-injectable oral or sublingual option, unusual at this price

Cons

• −Compounded is all you can actually buy. Its employer page says brand name is available alongside compounded tirzepatide and semaglutide, but no consumer page sells a brand product and the site has no Wegovy, Zepbound, Ozempic or Mounjaro page (rendered check 2026-09-03)
• −Obesity-certified doctors are advertised on the weight loss page, but no clinician roster or credentials are published, and no lab panels or blood work are offered anywhere on the site (rendered check 2026-09-03)
• −The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan

Pros

• +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
• +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
• +Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market

Cons

• −Founding year, corporate ownership and the legal entity behind the program are not published on wellorithm.com; the Terms describe it only as 'a Miami-based company' that connects patients with unnamed 'Professional Entities' (verified 2026-09-03). The program page and every medication page do name three partner physicians, and the contact page gives a Miami street address and phone, so the gap is corporate rather than clinical
• −49 states only, service is unavailable in Louisiana and outside the United States
• −Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month

Pros

• +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
• +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
• +With insurance the plan starts at $99/mo on a 12 month term, below its own $169/mo cash figure, plus a copay Found puts at around $30 for most members

Cons

• −The advertised prices need a 12 month plan paid up front. Found's pricing page lists $169/mo cash or $99/mo insured on that plan, and $289/mo cash or $199/mo insured if you pay month to month
• −The insurance route adds steps compared with flat cash-pay platforms, and the copay Found quotes at around $30 for most members is charged on top of the plan price, not instead of it
• −Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

Pros

• +Publishes a complete price ladder for both molecules, so what each advertised rate costs up front is checkable: semaglutide $79/$76/$73/$69 and tirzepatide $129/$126/$123/$119 across one, three, six and twelve months.
• +One-month injection prices of $79 for semaglutide and $129 for GLP-1 + GIP were visible in Embody's catalogue on September 20, 2026. The FAQ says the selected rate holds within the chosen plan.
• +Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.

Cons

• −Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. The twelve-month semaglutide plan commits $828 up front; cancellation requests must reach support at least 72 hours before the next billing date.
• −The public catalogue shows $69/$119 as twelve-month equivalents paid up front at $828/$1,428, while a separate promotion advertises those amounts monthly. Embody's [April-dated terms](https://joinem.co/pages/terms-conditions) still list different introductory and fixed-price programs. We have not verified which terms govern the final offer. Confirm the first charge, recurring charge and commitment before paying.
• −Trustpilot showed 3.8 / 5 across 8,121 reviews on 2026-09-20, while the landing page advertised 4.8 on our prior check. The Trustpilot profile includes merged reviews from another profile, and individual reports cover different pricing periods. It is not a measure of clinical quality.

Pros

• +The tirzepatide plus B12 program is one price for any dose, $209/mo, and the page says it does not go up as you titrate
• +PeterMD advertises more than 400,000 patients served and a 4.9 out of 5 rating from over 20,000 reviews
• +Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect

Cons

• −The excluded states differ by page: the GLP1 plus B12 program lists AL, ID, AK and HI, the tirzepatide page lists only AL and ID, and the intake form asks about Alabama, Arkansas, Idaho and Hawaii. Confirm your own state during signup before planning around PeterMD.
• −Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
• −PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.

Pros

• +Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149 to $299 a month depending on dose on its pricing page
• +Insurance support for the Wegovy pen, Zepbound autoinjector pen and Ozempic; coverage and copays are plan-dependent, with membership charged separately
• +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo prepaid annually, which its pricing page frames as a $900/year saving

Cons

• −Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
• −Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
• −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Pros

• +Gala's current microdose offer lists $149/mo on a 3-month plan; its all-doses GLP-1 page lists $179/mo yearly, while its main site lists 3-month standard GLP-1 from $199/mo
• +A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
• +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack

Cons

• −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
• −Plan prices differ by landing page: the microdose offer lists $149/mo for 3 months, the all-doses page $179/mo yearly, and the main site 3-month GLP-1 from $199/mo. Confirm the checkout total
• −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill

Pros

• +Competitive entry pricing: $179/mo for compounded semaglutide and $209/mo for compounded tirzepatide undercuts the mid-tier compounded average (~$199/$299) for both formats
• +Names both its clinicians and its pharmacies: the FAQ credits Lion MD, led by Dr. Ana Lisa Carr MD (NPI 1689841744) and Dr. Kelly Tenbrink MD (NPI 1346482684), and lists four partner pharmacies with phone numbers, Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx. Most compounded-only platforms in this price tier name neither, and a LegitScript certification seal sits in the footer of every page (verified 2026-09-03).
• +Multi-month bundles (1, 3, 6, 12 months) with cancel-anytime, no-monthly-membership flexibility, strong fit for users who want to lock in a price without subscription lock-in

Cons

• −Compounded-only, no brand-name FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or a brand-name oral GLP-1 pill. Compounded oral formats are offered for microdosing, but patients who want an FDA-approved finished product need a different provider for that piece.
• −The same supply carries different prices on different pages. The bundle selector shows tirzepatide at $179/mo for three months, while the tirzepatide product page charges $859 for the same three-month supply, which works out to $286.33/mo, so confirm the total on the page you actually check out from (verified 2026-09-03).
• −Operating entity is Dynamo Group LLC under a brand license, NOT Bodybuilding.com directly. The "Trusted by millions since 1999" framing describes the parent retail brand; the GLP-1 program launched in 2026 and stands on its own record.

Pros

• +4.5 stars across 4,627 Trustpilot reviews, 79% give 5 stars, and Eden has replied to 100% of negative reviews, typically within 48 hours (checked 2026-09-03).
• +Care comes from a national network of licensed doctors and nurse practitioners, with 24/7 clinician messaging included in the monthly price.
• +Provider-directed labwork is included when your clinician calls for it, at no extra charge on the plan we link to.

Cons

• −Eden's current public compounded GLP-1 page advertises $99 a month for semaglutide and $129 for tirzepatide with no separate membership fee. Brand-name treatment pages showed a separate membership charge when last checked September 12, 2026. The affiliate checkout could not be independently read today, so confirm your exact medication, first bill and renewal terms.
• −Cash-pay only, no insurance billing.
• −11% of Eden's 4,627 Trustpilot reviews are 1-star (checked 2026-09-03). Its terms require cancellation at least 48 hours before your renewal date and say cancellations do not apply to orders already processed or shipped, which is how people end up billed or shipped after they cancel.

Pros

• +A needle-free compounded semaglutide buccal lozenge is available if a clinician determines it is appropriate
• +Published auto-refill options: oral semaglutide from $99/mo, injectable semaglutide from $129/mo, injectable tirzepatide from $149/mo and oral tirzepatide from $199/mo; confirm the selected plan at checkout
• +Current semaglutide product pages include physician consultations and free shipping in the advertised price

Cons

• −Compounded only, no brand-name Wegovy or Zepbound. Strut does not publish formulation-specific pharmacokinetic or comparative outcome evidence for its oral lozenges, so their absorption and weight-loss results versus approved injections are unknown.
• −Compounded oral semaglutide is not FDA-approved as a finished product or established as bioequivalent to approved oral or injectable semaglutide; do not infer equivalent dosing or results

Pros

• +Publishes an outcomes figure: some members self reported losing an average of 6.4% of body weight in their first 12 weeks (verified 2026-09-03)
• +Each patient gets an assigned licensed clinician, with clinical messaging inside the account and a short check in before every refill
• +The monthly price does not rise as the dose does, and provider review, free shipping and telehealth support are included at every tier

Cons

• −The $110/mo headline requires a 6 month plan, month to month is $149/mo, and once a prescription reaches the pharmacy nothing is refundable, so the cheapest rate is also the one with the least room to change your mind
• −No insurance accepted or billed, and no HSA, FSA or superbill information is shown on the site's product, FAQ, terms or refund pages (rendered check 2026-09-03)

Pros

• +One of the few compounded providers offering both oral tablets and injectable semaglutide
• +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
• +Sleek onboarding experience with clear progress tracking through their patient portal

Cons

• −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
• −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
• −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148

Pros

• +One intake covers compounded GLP-1 and GLP-1 + GIP injections plus compounded oral versions of both
• +The offer page checked September 3 advertised a $149 entry floor for GLP-1 and $249 for GLP-1 + GIP, although neither figure matches the medication schedule in the official terms
• +The intake is a short online assessment with no video call, and the terms say compounded medication generally ships within 48 business hours of the prescription reaching the pharmacy

Cons

• −The $149 floor on an offer page checked September 3 is not what TrimRx's own terms charge: GLP-1 is listed there at $199 for the first month then $299, and GLP-1 + GIP at $349 then $399. Its homepage advertises a third pair of figures, $179 and $259, so confirm the exact charge at checkout
• −Trustpilot is 3.6/5 across 5,632 reviews with 32% one star, checked 2026-09-03; BBB rated TrimRx F and not accredited with 728 unanswered and 221 unresolved complaints when we last read the profile on August 14, 2026
• −The same paid-but-no-medication, billing, refund and fulfillment themes recur across BBB and Trustpilot, meeting our rubric's cross-platform -3.0 fulfillment-failure threshold

Pros

• +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
• +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
• +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance

Cons

• −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
• −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
• −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care

Pros

• +Four product-specific options to discuss with a clinician: semaglutide or tirzepatide, each as an injection or a dissolving tablet
• +$99 for the first month on both the compounded semaglutide and the compounded tirzepatide injection, quoted on each product page, among the lowest entry rates in the compounded segment
• +Fast onboarding: a short online intake, a prescription within 24 hours where no video visit is required, and free overnight shipping on all orders with tracking within 2 business days

Cons

• −Every advertised price is a first month rate and SkinnyRx does not publish what month two costs. Its terms say the renewal rate is described at checkout, and that discounts may be reversed if you cancel before the end of a promotional or committed term.
• −SkinnyRx names its medical director, Sajad Zalzala, M.D., and names AyaRx as the telemedicine partner behind its medical services, but it does not name the compounding pharmacy that fills prescriptions and it publishes no founders or executive team.
• −Cash-pay only, does not bill commercial insurance, Medicare, or Medicaid. HSA/FSA payments are accepted, which is the main way to soften the cost.

Pros

• +$99/mo compounded semaglutide on the 12-month plan, with a $133/mo 3-month option
• +Flat pricing across doses, clinician review, dose adjustments, and overnight shipping included
• +Independent US-licensed clinicians in all 50 states, with the homepage saying a board-certified physician reviews your file within 24 hours

Cons

• −The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site
• −Legal entity, headquarters, executive team, and medical director remain undisclosed
• −The $99/mo semaglutide headline needs $1,188 paid up front for a full year. Buying month to month costs $190 on its pricing page, verified 2026-09-03

Pros

• +Advertised starting rate of $79.99/mo for compounded semaglutide, among the lowest headline prices we track; the same page also shows $150 per month, and lab work is billed separately
• +Compounded plans are flat rate across every dose, so titrating up does not reprice your plan
• +Maximus adds glycine and B12 to its compounded semaglutide, described on the site as a way to further customize and tailor the medication; it cites no clinical evidence for the combination

Cons

• −The advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw
• −The fulfilling pharmacies are named only as initials in the help center, EVR, FCC or VIOS by state for compounded medication and The Pharmacy Hub for brand-name, and not on the product pages a shopper actually reads
• −Brand-name plans are priced by dose tier, so titrating up can move you to a higher monthly rate; compounded plans stay flat across all doses

Pros

• +Compounded starting prices are visible before intake, with consultation and delivery included at entry
• +Names OpenLoop Health and four pharmacy partners: RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
• +Advertises included labs; the specific tests and requirements need confirmation with the provider

Cons

• −Brand-name cards show membership fees only: $99 for Zepbound or Wegovy and $171 for Ozempic, with medication charged separately
• −No published dose-by-dose or renewal price schedule; confirm the ongoing total before enrolling
• −The dissolvable tablet's active ingredient is not identified on the treatment page

Pros

• +$59/mo compounded semaglutide and $69/mo compounded tirzepatide, with the medication price advertised as flat at every dose
• +Medication is billed month to month rather than through a required multi-month medication prepayment
• +Two-day express cold shipping, clinician review, unlimited doctor messaging, and nutrition and lifestyle support are included

Cons

• −The $59 and $69 medication headlines exclude a required $199 annual membership after a 21-day trial
• −The terms permit a nominal technology transaction fee for each electronic prescription but publish no amount
• −No dispensing pharmacy, individual clinician or medical director is publicly named

Pros

• +A public plan grid: semaglutide at $99, $89, $79 and $69/mo across one, three, six and twelve months, and tirzepatide at $149, $139, $129 and $119. Longer terms are paid upfront
• +Names four partner pharmacies in its footer with full street addresses and phone numbers, Red Rock Compounding, Health Warehouse, Precision Medicine and Triad Rx, which most competitors do not do
• +Evaluation, prescribed medication, support and shipping are advertised as included; the stated 1-2 day shipping is an estimate, not a guarantee

Cons

• −A small independent review sample: Trustpilot showed 3.1/5 from 7 reviews on October 1, 2026. It cannot establish a typical experience or corroborate the homepage's customer-count claim
• −The homepage leads the 12-month rate ($69/mo, billed $828 once) under a countdown timer that re-seeds on each visit instead of counting down to a dated deadline, while the month-to-month rate is $99
• −Cancellation normally stops future renewal without refunding the prepaid term. The terms say to cancel at least 5 days before the period ends; the refund policy says 72 hours before billing. Confirm the cutoff and keep written confirmation

Pros

• +$99/mo compounded semaglutide on the annual plan (billed $1,188 once yearly) is among the cheapest flat recurring rates we track; tirzepatide annual is $125/mo ($1,500 yearly)
• +Flat pricing across all doses, your monthly price does not rise as your dose titrates up
• +Consult and overnight shipping included in the plan price, no add-on fees; HSA/FSA accepted, Klarna and Affirm financing available

Cons

• −Trustpilot has withheld Trimi's star rating for a breach of its review guidelines and says it removed a number of fake reviews. Of the 55 reviews displayed, 64 percent are one star (checked 2026-09-23). Recent reviewers report fulfillment, refund and certificate-of-analysis concerns; these individual accounts do not establish medication quality
• −Once a prescription is signed, payments are final, no pro-rating, cancelling an annual plan mid-year forfeits the remainder. Full refund is available only BEFORE the prescription is signed
• −The site names New York City as its base but publishes no street address and no legal entity name, calling itself only 'Trimi Health' with no LLC or Inc suffix on its contact, about, terms or FAQ pages (rendered check 2026-09-03)

Pros

• +Published $199 monthly GLP-1Rx offer with care and medication if prescribed
• +Connected app for logging and program support
• +Independent clinical network and legal entity identified in terms

Cons

• −No verified dispensing pharmacy in the sources reviewed
• −Oral formulation and dose-specific prices are not sufficiently clear to compare
• −Clinical-leadership details differ across public pages

Pros

• +Publishes a price on every medication page and a full 4-week grid on /pricing, with no intake required to see either
• +Three compounded formats including oral semaglutide tablets, plus a dedicated microdosing line with its own products
• +Published cancellation and refund terms explain the notice period and limits on prepaid-plan refunds

Cons

• −Ozempic is listed at $1,299 and Zepbound at $1,399 per four-week cycle. No longer-plan brand discount is published. Compare the same prescribed brand, dose, supply and included services before choosing a cash-pay offer
• −Prices are headlined per week and billed per 4-week cycle, so a 4-week charge lands 13 times a year rather than 12; the 12, 24 and 52-week plans are priced as one total instead, so compare totals rather than weekly rates
• −The cheapest weekly rates need a full year paid as one total: on its pricing page semaglutide injection is $45 a week only as a $2,327 52-week plan, and tirzepatide $67 a week only as a $3,497 52-week plan